Jaguar Health (JAGX) Current Deferred Revenue (2014 - 2026)
Jaguar Health's (JAGX) quarterly Current Deferred Revenue came in at $170000.0 in Q1 2026, little changed year-on-year from $170000.0 in Q1 2025, and little changed on a QoQ basis from $170000.0 in Q4 2025.
Jaguar Health (JAGX) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 8 years of Current Deferred Revenue data on file, last reported at $170000.0 in Q1 2026.
- On a quarterly basis, Current Deferred Revenue changed 0.0% year-over-year to $170000.0 in Q1 2026; TTM through Mar 2026 was $170000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $170000.0, changed 0.0% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $170000.0, roughly flat from $170000.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for JAGX reached as high as $170000.0 in Q1 2024 and fell as low as $170000.0 in Q1 2024.
- Historically, Current Deferred Revenue has averaged $170000.0 across 3 years, with a median of $170000.0 in 2024.
- On a YoY basis, Current Deferred Revenue climbed as much as 0.0% in 2025 and fell as far as 0.0% in 2025.
- Year by year, Current Deferred Revenue stood at $170000.0 in 2024, then changed by 0.0% to $170000.0 in 2025, then changed by 0.0% to $170000.0 in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $170000.0 in Q1 2026, $170000.0 in Q4 2025, and $170000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 170,000.00 |
| Sep 30, 2024 | 170,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | 170,000.00 |
| Jun 30, 2020 | 1.50 Mn |
| Dec 31, 2017 | 177,389.00 |
| Sep 30, 2017 | 224,448.00 |
| Jun 30, 2017 | 184,674.00 |
| Mar 31, 2017 | 208,258.00 |
| Dec 31, 2016 | 224,454.00 |
| Sep 30, 2016 | 246,235.00 |
| Jun 30, 2016 | 262,666.00 |
| Mar 31, 2016 | 279,065.00 |
| Dec 31, 2015 | 251,936.00 |
| Sep 30, 2015 | 336,712.00 |